131 related articles for article (PubMed ID: 34384564)
1. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.
Sunagawa Y; Shimizu K; Katayama A; Funamoto M; Shimizu K; Nurmila S; Shimizu S; Miyazaki Y; Katanasaka Y; Hasegawa K; Morimoto T
J Pharmacol Sci; 2021 Oct; 147(2):169-175. PubMed ID: 34384564
[TBL] [Abstract][Full Text] [Related]
2. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
4. SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300.
Shen P; Feng X; Zhang X; Huang X; Liu S; Lu X; Li J; You J; Lu J; Li Z; Ye J; Liu P
J Pharmacol Sci; 2016 Sep; 132(1):31-40. PubMed ID: 27094368
[TBL] [Abstract][Full Text] [Related]
5. JNK signaling-dependent regulation of histone acetylation are involved in anacardic acid alleviates cardiomyocyte hypertrophy induced by phenylephrine.
Peng B; Peng C; Luo X; Wu S; Mao Q; Zhang H; Han X
PLoS One; 2021; 16(12):e0261388. PubMed ID: 34914791
[TBL] [Abstract][Full Text] [Related]
6. The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice.
Shimizu K; Sunagawa Y; Funamoto M; Wakabayashi H; Genpei M; Miyazaki Y; Katanasaka Y; Sari N; Shimizu S; Katayama A; Shibata H; Iwabuchi Y; Kakeya H; Wada H; Hasegawa K; Morimoto T
Sci Rep; 2020 Apr; 10(1):7172. PubMed ID: 32346115
[TBL] [Abstract][Full Text] [Related]
7. The polyunsaturated fatty acids, EPA and DHA, ameliorate myocardial infarction-induced heart failure by inhibiting p300-HAT activity in rats.
Sunagawa Y; Katayama A; Funamoto M; Shimizu K; Shimizu S; Sari N; Katanasaka Y; Miyazaki Y; Hosomi R; Hasegawa K; Morimoto T
J Nutr Biochem; 2022 Aug; 106():109031. PubMed ID: 35504444
[TBL] [Abstract][Full Text] [Related]
8. The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity.
Gusterson RJ; Jazrawi E; Adcock IM; Latchman DS
J Biol Chem; 2003 Feb; 278(9):6838-47. PubMed ID: 12477714
[TBL] [Abstract][Full Text] [Related]
9.
Katagiri T; Sunagawa Y; Maekawa T; Funamoto M; Shimizu S; Shimizu K; Katanasaka Y; Komiyama M; Hawke P; Hara H; Mori K; Hasegawa K; Morimoto T
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276939
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes.
Yoshida Y; Morimoto T; Takaya T; Kawamura T; Sunagawa Y; Wada H; Fujita M; Shimatsu A; Kita T; Hasegawa K
Circ J; 2010 Jan; 74(1):156-62. PubMed ID: 19966502
[TBL] [Abstract][Full Text] [Related]
11. Phenylephrine-induced cardiac hypertrophy is attenuated by a histone acetylase inhibitor anacardic acid in mice.
Peng C; Luo X; Li S; Sun H
Mol Biosyst; 2017 Mar; 13(4):714-724. PubMed ID: 28194469
[TBL] [Abstract][Full Text] [Related]
12. Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice.
Sunagawa Y; Tsukabe R; Irokawa Y; Funamoto M; Suzuki Y; Yamada M; Shimizu S; Katanasaka Y; Hamabe-Horiike T; Kawase Y; Naruta R; Shimizu K; Mori K; Hosomi R; Komiyama M; Hasegawa K; Morimoto T
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397020
[TBL] [Abstract][Full Text] [Related]
13. 6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure.
Kawase Y; Sunagawa Y; Shimizu K; Funamoto M; Hamabe-Horiike T; Katanasaka Y; Shimizu S; Hawke P; Mori K; Komiyama M; Hasegawa K; Morimoto T
Nutrients; 2023 May; 15(9):. PubMed ID: 37432400
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by Phenylephrine.
Zhao Z; Lv J; Guo N; Guo Q; Zeng S; Fang Y; Chen W; Wang Z
Curr Drug Targets; 2023; 24(4):371-378. PubMed ID: 36734909
[TBL] [Abstract][Full Text] [Related]
15. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
Dong B; Xue R; Sun Y; Dong Y; Liu C
Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
[TBL] [Abstract][Full Text] [Related]
16. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
17. Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex.
Funamoto M; Sunagawa Y; Gempei M; Shimizu K; Katanasaka Y; Shimizu S; Hamabe-Horiike T; Appendino G; Minassi A; Koeberle A; Komiyama M; Mori K; Hasegawa K; Morimoto T
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745840
[TBL] [Abstract][Full Text] [Related]
18. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300.
Duan Y; Zhou B; Su H; Liu Y; Du C
Exp Cell Res; 2013 Feb; 319(3):173-84. PubMed ID: 23211718
[TBL] [Abstract][Full Text] [Related]
19. CaMKIIδ meditates phenylephrine induced cardiomyocyte hypertrophy through store-operated Ca
Ji Y; Guo X; Zhang Z; Huang Z; Zhu J; Chen QH; Gui L
Cardiovasc Pathol; 2017; 27():9-17. PubMed ID: 27940402
[TBL] [Abstract][Full Text] [Related]
20. Compensatory upregulation of the adenosine system following phenylephrine-induced hypertrophy in cultured rat ventricular myocytes.
Pang T; Gan XT; Freeman DJ; Cook MA; Karmazyn M
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H545-53. PubMed ID: 19966059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
